Search research articles
Contact Us
Filters
Showing results (51-60 of 236) with videos related to
Page
of 24
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 1, 2023
Molecular Landscape of Mullerian Clear Cell Carcinomas Identifies The Cancer Genome Atlas-like Prognostic Subgroups
Lina Irshaid, Danielle C Costigan, Fei Dong, et al.
BMC Cancer
|
March 14, 2020
An immune-centric exploration of BRCA1 and BRCA2 germline mutation related breast and ovarian cancers
Ewa Przybytkowski, Thomas Davis, Abdelrahman Hosny, et al.
JCO Precision Oncology
|
March 5, 2019
Targeted Next-Generation Sequencing Reveals Clinically Actionable <i>BRAF</i> and <i>ESR1</i> Mutations in Low-Grade Serous Ovarian Carcinoma
Elizabeth H Stover, Colleen Feltmate, Ross S Berkowitz, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
February 19, 2024
Phenotypes of hypersensitivity reactions to pegylated liposomal doxorubicin: Safety and efficacy of 128 rapid desensitizations
Katherine L Tuttle, Donna-Marie Lynch, Kathleen Marquis, et al.
Gynecologic Oncology
|
April 7, 2016
Moving beyond the platinum sensitive/resistant paradigm for patients with recurrent ovarian cancer
Ronald D Alvarez, Ursula A Matulonis, Thomas J Herzog, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 15, 2010
Place of death: correlations with quality of life of patients with cancer and predictors of bereaved caregivers' mental health
Alexi A Wright, Nancy L Keating, Tracy A Balboni, et al.
Journal of Psychosocial Oncology
|
July 4, 2012
Young women diagnosed with early-stage ovarian cancer or borderline malignancy of the ovary: a focus on fertility and sexual function
Susana M Campos, Suzanne Berlin, Ursula A Matulonis, et al.
Journal of Geriatric Oncology
|
December 21, 2024
The pervasive impact of frailty on ovarian cancer care and the role of prehabilitation: Qualitative perspectives of key stakeholders
Stephanie Cham, Rachel A Pozzar, Neil Horowitz, et al.
Gynecologic Oncology
|
June 26, 2018
Durable response in a woman with recurrent low-grade endometrioid endometrial cancer and a germline BRCA2 mutation treated with a PARP inhibitor
Allison A Gockley, David L Kolin, Christopher S Awtrey, et al.
Gynecologic Oncology
|
July 18, 2025
The RAS-MEK-ERK pathway in low-grade serous ovarian cancer
Elizabeth H Stover, Elizabeth K Lee, Geoffrey I Shapiro, et al.
Page
of 24
Search research articles
Search
Showing results (51-60 of 236) with videos related to
Sort By:
Page
of 24
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 1, 2023
Molecular Landscape of Mullerian Clear Cell Carcinomas Identifies The Cancer Genome Atlas-like Prognostic Subgroups
Lina Irshaid, Danielle C Costigan, Fei Dong, et al.
BMC Cancer
|
March 14, 2020
An immune-centric exploration of BRCA1 and BRCA2 germline mutation related breast and ovarian cancers
Ewa Przybytkowski, Thomas Davis, Abdelrahman Hosny, et al.
JCO Precision Oncology
|
March 5, 2019
Targeted Next-Generation Sequencing Reveals Clinically Actionable <i>BRAF</i> and <i>ESR1</i> Mutations in Low-Grade Serous Ovarian Carcinoma
Elizabeth H Stover, Colleen Feltmate, Ross S Berkowitz, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
February 19, 2024
Phenotypes of hypersensitivity reactions to pegylated liposomal doxorubicin: Safety and efficacy of 128 rapid desensitizations
Katherine L Tuttle, Donna-Marie Lynch, Kathleen Marquis, et al.
Gynecologic Oncology
|
April 7, 2016
Moving beyond the platinum sensitive/resistant paradigm for patients with recurrent ovarian cancer
Ronald D Alvarez, Ursula A Matulonis, Thomas J Herzog, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 15, 2010
Place of death: correlations with quality of life of patients with cancer and predictors of bereaved caregivers' mental health
Alexi A Wright, Nancy L Keating, Tracy A Balboni, et al.
Journal of Psychosocial Oncology
|
July 4, 2012
Young women diagnosed with early-stage ovarian cancer or borderline malignancy of the ovary: a focus on fertility and sexual function
Susana M Campos, Suzanne Berlin, Ursula A Matulonis, et al.
Journal of Geriatric Oncology
|
December 21, 2024
The pervasive impact of frailty on ovarian cancer care and the role of prehabilitation: Qualitative perspectives of key stakeholders
Stephanie Cham, Rachel A Pozzar, Neil Horowitz, et al.
Gynecologic Oncology
|
June 26, 2018
Durable response in a woman with recurrent low-grade endometrioid endometrial cancer and a germline BRCA2 mutation treated with a PARP inhibitor
Allison A Gockley, David L Kolin, Christopher S Awtrey, et al.
Gynecologic Oncology
|
July 18, 2025
The RAS-MEK-ERK pathway in low-grade serous ovarian cancer
Elizabeth H Stover, Elizabeth K Lee, Geoffrey I Shapiro, et al.
Page
of 24